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Materials and Methods

Sample Groups
Peripheral blood samples were obtained from 27 CRC patients no more than 7 days prior to primary colorectal tumor resection (patient characteristics are detailed in Supplementary 
Antigens
Forty-one 20mer peptides overlapping by 10 amino acids covering the entire human 5T4 protein were synthesized by Fmoc chemistry to >95% purity (GL Biochem, Shanghai, China) ( Figure 1A ). The peptides were divided into 13 pools ( Figure 1B ). Whole 5T4 protein was produced as previously described (14) . Tuberculin Purified Protein Derivative (PPD) (Statens Serum Institut, Denmark) and phtohaemagglutinin (PHA) (Sigma) were used as controls. All antigens were used at a final concentration of 10 μg/ml.
Lymphocyte Purification and Culture
PBMC purification and growth of short-term lines were performed as described (15) . Briefly, PBMCs were isolated from heparinized blood by IU/ml IL-2 on days 6 and 9. The effect of Treg-depletion from PBMC on antigen-specific IFN-γ production was assessed in parallel assays using hi cells, as previously described (7).
ELISpot Assays
Polymer-backed 96-well filtration plates (MAIP-S-4510) (Millipore, Moslheim, France) were used for all ELISpot assays. Antibodies were obtained from Mabtech (Natka, Sweden) and the ELISpot assay was developed using the alkaline phosphatase substrate kit from Bio-Rad 
T cell Cloning
To generate 5T4-specific CD4 
Statistical Analysis
GraphPad 
Results
5T4-specific T cell responses are detectable in the memory pool of both CRC patients and healthy controls
Using whole protein antigen, we have previously detected ex vivo 5T4-specific T cell responses in patients with CRC (6, 7), but not in healthy donors. The low frequency measured ex vivo renders detailed characterization of the response difficult. In order to facilitate the characterization of these responses we establish short-term T cell cultures using PBMCs from HLA-typed subjects, stimulated with pools of 20mer 5T4 peptides spanning the entire protein ( Figures 1A and 1B) . Culturing PBMC led to expansion of antigen-specific T cells to more readily detectable levels, allowing the frequency of cognate Th1 cells in these short-term lines to be detected by IFN-γ release. Previously we have found that these cultured responses reflect a central memory population of T cells compared to an effector population identified by ex vivo assays (15) . This change in methodology may account for why we now identify a population of 5T4-specific T cells in both patients ( Figure 1C ) as well as healthy controls ( Figure   1D ). The experiment using cells from one representative patient ( Figure 1C These data demonstrate a steady decrease in the responsiveness of T cells to 5T4 measured by IFN-γ production in patients with increasingly advanced colorectal tumors. Despite this, T cell immunity to the recall antigen, PPD, was unaffected ( Figure 2C ), thus there does not appear to be nonspecific immunosuppression, as we and others have previously noted (6, 16 ).
In the cohort of patients tested, 6 of 13 with local lymph node spread produced no detectable 5T4 T cell response post-culture, whereas every patient whose tumor was contained to the bowel wall produced a 5T4 response (106. 
5T4 responses are CD4 + T cells restricted by HLA-DR antigens
The influence of age and HLA-DR antigens on 5T4 T cell responses
Increased age has been associated with a decline in T cell function leading to the concept of immune senescence and susceptibility to infectious diseases and cancer (19) . We have shown that healthy age-matched donors produce better responses than CRC patients. We also found that patients ≤ 
The influence of Tregs on 5T4 T cell responses
Tregs have been shown to actively impinge on 5T4-specific antitumor T cell responses (6, 7, 12) . It is also well-documented that patients with cancer have increased frequencies of Tregs, as denoted by Foxp3 expression (20) .
We have shown that surgical resection of CRC reduces the proportion of responses in certain cases, as suggested in previous ex vivo analyses (7, 12) .
Additionally, these cultured responses were confined to the CD45RO + T cells 
We used the oncofetal antigen 5T4 as a candidate tumor-specific antigen. Utilizing 41 overlapping 20mer peptides allowed an unbiased approach to epitope-mapping and negated the requirement for peptide binding algorithm software, as 5T4 peptides with high HLA binding affinities may not necessarily be those recognized in vivo due to thymic deletion. It was surprising that such robust responses to these peptides were found in healthy controls, although previous reports also described robust responses to some tumor associated antigens in cancer-free individuals (23) . Collectively, these findings raised important questions regarding how and why these T cells are 
